MEDP Medpace Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MEDP

Price (delayed)

$458.68

Market cap

$13.1B

P/E Ratio

28.28

Dividend/share

N/A

EPS

$16.22

Enterprise value

$12.57B

?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 48
Relative Valuation: Rel. Valuation: 45
Relative Profitability: Rel. Profitability: 50

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate ...

Highlights
Medpace Holdings's equity has increased by 30% from the previous quarter
MEDP's revenue is up by 24% year-on-year and by 6% since the previous quarter
The debt is up by 8% since the previous quarter but it is down by 3.5% year-on-year
Medpace Holdings's gross margin has decreased by 8% YoY and by 3.3% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.medpace.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of MEDP

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
1.74%
1 week
2.36%
1 month
9.99%
1 year
46.66%
YTD
-18.33%
QTD
-4.48%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$2.68B
Gross profit
$778.59M
Operating income
$562.92M
Net income
$460.4M
Gross margin
29.1%
Net margin
17.2%
MEDP's revenue is up by 24% year-on-year and by 6% since the previous quarter
The operating income has increased by 23% year-on-year and by 5% since the previous quarter
MEDP's gross profit is up by 15% year-on-year and by 2.4% since the previous quarter
The net income has increased by 11% YoY and by 2.1% from the previous quarter

Price vs fundamentals

How does MEDP's price correlate with its fundamentals

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
MEDP P/E details
P/E
28.28
P/B
21.76
P/S
4.87
EV/EBIT
22.48
EV/EBITDA
20.61
EV/Sales
4.69
The EPS is up by 20% YoY and by 3.7% QoQ
The P/E is 10% lower than the last 4 quarters average of 30.8 and 9% lower than the 5-year quarterly average of 30.5
MEDP's price to book (P/B) is 46% lower than its last 4 quarters average of 39.7 but 11% higher than its 5-year quarterly average of 19.2
Medpace Holdings's equity has increased by 30% from the previous quarter
MEDP's revenue is up by 24% year-on-year and by 6% since the previous quarter
MEDP's price to sales (P/S) is 11% less than its last 4 quarters average of 5.4 and 6% less than its 5-year quarterly average of 5.1

Efficiency

How efficient is Medpace Holdings business performance
The company's return on equity has surged by 122% YoY
Medpace Holdings's return on assets has increased by 19% YoY

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 39% higher than its total liabilities
Medpace Holdings's quick ratio has increased by 18% YoY and by 16% QoQ
The total liabilities has grown by 17% YoY
The debt is 80% smaller than the equity
Medpace Holdings's equity has increased by 30% from the previous quarter
MEDP's debt to equity is down by 20% since the previous quarter and by 4.8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.